Lumida
/BBNX
⌘K
Beta Bionics Inc

Beta Bionics Inc

BBNX
$16.57USD-0.12%-0.02 today

MARKET CAP

745.5M

P/E (TTM)

FWD P/E

DAY RANGE

$16 – $17

52W RANGE

$9
$33

AI Summary

Stalk
StalkMedium

BBNX remains in a Stage 2 uptrend with successive higher highs and higher lows above rising EMAs. The medium-term bias is bullish, but short-term price is extended above EMAs and in extreme overbought RSI territory, warranting patience. Preferred entries are on pullbacks into the 9- and 20-day EMA support zone for continuation participation.

  • Q2 sales hit $32M, up 38% YoY from patient starts
  • Raised gross margin outlook to 58.5–59.5%, driven by pharmacy model
  • FDA warning letter on complaints handling risks product approvals
Full analysis →

Buying

9

institutions

Selling

7

institutions

New Positions

3

this quarter

Filing Period

Q2 2026

latest 13-F

13-F Holdings

InstitutionActionShares HeldValueChangeChg %Weight
BI

Blackrock, Inc.

Q2 2026

BUY3.34 M52.34 M+301.58 K+71.9%0.00%
FC

Farallon Capital Management LLC

Q1 2026

SELL3.61 M36.15 M+-706.00 K-72.5%0.00%
PA

Point72 Asset Management, L.P.

Q2 2026

SELL2.25 M35.33 M+-270.36 K+39.6%0.04%
RI

Rtw Investments, LP

Q2 2026

SELL1.50 M23.50 M+-500.00 K+17.3%0.20%
EP

Eversept Partners, LP

Q2 2026

SELL1.25 M19.58 M+-165.40 K+38.1%1.02%
MM

Millennium Management LLC

Q2 2026

BUY956.24 K14.98 M+95.38 K+73.7%0.01%
BA

Balyasny Asset Management L.P.

Q2 2026

BUY855.68 K13.41 M+237.77 K+116.6%0.02%
PA

Perceptive Advisors LLC

Q2 2026

SELL832.94 K13.05 M+-852.94 K-22.7%0.20%
JC

Jpmorgan Chase & Co

Q2 2026

BUY703.36 K11.96 M+396.13 K+294.7%0.00%
FC

Farallon Capital Management, L.l.c.

Q2 2026

BUYNEW595.00 K9.32 M+595.00 K+0.0%0.04%
AC

Aqr Capital Management LLC

Q2 2026

BUY308.47 K4.83 M+248.18 K+700.2%0.00%
CA

Citadel Advisors LLC

Q2 2026

SELL40.40 K633.07 K+-37.04 K-18.4%0.00%
BH

Brevan Howard Capital Management LP

Q2 2026

BUYNEW33.65 K527.36 K+33.65 K+0.0%0.00%
MG

Man Group Plc

Q2 2026

SELL26.77 K419.49 K+-12.50 K+6.6%0.00%
RT

Renaissance Technologies LLC

Q2 2026

BUYNEW11.30 K177.07 K+11.30 K+0.0%0.00%
RC

Rockefeller Capital Management L.P.

Q2 2026

BUY1.30 K20.45 K+632.00+203.2%0.00%